Skip to content

A study of the effects of ginger moxibustion therapy on health-related quality of life in patients with diabetic peripheral neuropathy

A study of the effects of ginger moxibustion therapy on health-related quality of life in patients with diabetic peripheral neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001496
Enrollment
Unknown
Registered
2025-07-26
Start date
2025-08-10
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic peripheral neuropathy

Interventions

Intervention Group:Conventional care combined with ginger-partitioned moxibustion
Control Group: Conventional care

Sponsors

Tianhui Xu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria Eligible participants were adults (=18 years) with confirmed diabetic peripheral neuropathy (DPN) diagnosed after diabetes onset. Patients presented with characteristic neuropathic symptoms (spontaneous pain burning/lancinating sensations nocturnal exacerbation) predominantly in lower limbs confirmed by abnormal nerve conduction in =2 nerves (median/ulnar/peroneal motor or sensory nerves). All participants provided informed consent.

Exclusion criteria

Exclusion criteria: 1)Those who combine with peripheral neuropathy not caused by other reasons such as diabetes mellitus; 2) Those with acute complications such as diabetic ketoacidosis severe infections skin breakdown of the lower limbs or hyperosmolar coma; 3) Those with skin infection skin breakdown or serious skin lesions in the moxibustion site; 4) Patients who are allergic to moxibustion; 5) Patients who have recently received other interventional therapies (e.g. acupuncture herbal foot baths physiotherapy etc.) that may affect the results of this study; (vi) Pregnant or lactating women; (vii) Patients with severe hepatic renal or cardiac insufficiency malignant tumours cardiovascular diseases or a history of severe mental illness. Translated with DeepL.com (free version)

Design outcomes

Primary

MeasureTime frame
Torontoclinicalscoring system;

Secondary

MeasureTime frame
Nerve Conduction Velocity;Self-Regulatory Scale;Chinese Medicine Evidence Scoring Criteria;Diabetes Specific Quality of Life Scale;Lubben Social Network Scale;Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactQin Wang

The Second Xiangya Hospital of Central South University

wangqin3421@csu.edu.cn18774806226

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026